Glaukos pens new deal for Preserflo MicroShunt

by Myles Hume

May 25, 2021

Home Tag US

US

At 250 microns, iTrack comprises an infusion pathway for the delivery of OVD, a fiber optic and a guide wire.

New iTrack trial comparing efficacy and safety ab-interno canaloplasty

March 3, 2021

Nova Eye Medical has announced eight surgery centres across the US have commenced a prospective, randomised clinical trial to assess ...

1-800 Contacts was founded 25 years ago and is now one of the world's largest contact lens retailers.

Major contact lens retailer snapped up in multi-billion-dollar deal

by Myles Hume

December 4, 2020

A global investment firm has acquired the US’s largest contact lens retailer 1-800 Contacts for a reported $AU4.2 billion. The ...

The ATO's R&D Tax Incentive enables companies to receive 43.5% of eligible research and development expenditure.

Tax credit strengthens Opthea’s balance sheet; follows AU$175m IPO on US exchange

by Myles Hume

November 18, 2020

Melbourne biopharmaceutical company Opthea has received an $8.5 million research and development (R&D) tax credit from the Australian tax authority ...

Advocates believe the measure will costs optometrists thousands of dollars in compliance costs.

AOA galvanises to fight controversial contact lens rule

by Myles Hume

October 2, 2020

Opposition in the US is gathering against a new ruling which allows patients to comparison shop for contact lenses with ...

GrandVision in Verona, Italy, is one of thousands of stores that could fall under the control of EssilorLuxottica.

EssilorLuxottica and GrandVision deal hits stumbling block

by Myles Hume

July 27, 2020

EssilorLuxottica has launched legal action against global optician group GrandVision as it seeks information on how the firm has been ...

Mojo's contact lens layers digital images and information into the wearer’s field of vision. Image: Mojo

Smart contact lens developer earns major backing

by Myles Hume

July 2, 2020

Start-up Mojo Vision has raised more than US$51 million (AU$77 million) in new funding to accelerate the development of what ...

The American Medical Association’s United States Adopted Names (USAN) Council, with the WHO, approved the name.

Drug developer hits major milestone with Lucentis biosimilar

by Myles Hume

May 22, 2020

A biopharmaceutical company that is developing cheaper anti-VEGF treatments for major global markets, including Australia, has reported positive results from ...